Novel Product for the Management of Coronary Ruptures Happening during Percutaneous Coronary Interventions
暂无分享,去创建一个
[1] S. Signorelli,et al. Spontaneous bleeding in systemic lupus erythematosus: Endovascular treatment of two rare cases , 2020, Radiology case reports.
[2] U. von Holzen,et al. Effectiveness of hemostatic agents in thyroid surgery for the prevention of postoperative bleeding , 2020, Scientific Reports.
[3] K. Garratt,et al. Guidewire-induced coronary artery perforation and tamponade during PCI: in-hospital outcomes and impact on long-term survival. , 2014, The Journal of invasive cardiology.
[4] M. Mamas,et al. Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] G. Veress,et al. Successful sealing of a coronary artery perforation with a mesh-covered stent. , 2012, The Journal of invasive cardiology.
[6] A. Shimony,et al. Coronary artery perforation during percutaneous coronary intervention: a systematic review and meta-analysis. , 2011, The Canadian journal of cardiology.
[7] A. Colombo,et al. Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation. , 2011, JACC. Cardiovascular interventions.
[8] D. Zahger,et al. Incidence, risk factors, management and outcomes of coronary artery perforation during percutaneous coronary intervention. , 2009, The American journal of cardiology.
[9] R. Sindwani,et al. Advances in absorbable biomaterials and nasal packing. , 2009, Otolaryngologic clinics of North America.
[10] Michael S. Lee,et al. Coronary perforation after percutaneous coronary intervention successfully treated with local thrombin injection. , 2006, The Journal of invasive cardiology.